MilliporeSigma
All Photos(2)

700132P

Avanti

3β,7α,25-trihydroxy-5-cholestenoic acid

Avanti Polar Lipids 700132P, powder

Synonym(s):
cholest-5-en-26-oic acid, 3β,7α,25-trihydroxy
Empirical Formula (Hill Notation):
C27H44O5
CAS Number:
Molecular Weight:
448.64
NACRES:
NA.25

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 mg (700132P-1mg)

manufacturer/tradename

Avanti Polar Lipids 700132P

shipped in

dry ice

storage temp.

−20°C

SMILES string

O[C@H](C1)CC[C@](C1=C[C@H]2O)(C)C3C2C(CC[C@@H]4[C@H](C)CCCC(C)(O)C(O)=O)[C@]4(C)CC3

General description

3β,7α,25-trihydroxy-5-cholestenoic acid is synthesized from 3β, 25-dihydroxy-5-cholestenoic acid in the presence of enzyme 25-hydroxycholesterol 7α-hydroxylase (CYP7B1). It is also synthesized from 7α,25-dihydroxycholesterol by the action of enzyme sterol 27-hydroxylase (CYP27A1).

Biochem/physiol Actions

3β,7α,25-trihydroxy-5-cholestenoic acid is used in the synthesis of 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acid by using cholesterol oxidase.

Packaging

5 mL Amber Glass Screw Cap Vial (700132P-1mg)

Storage Class Code

13 - Non Combustible Solids

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

More Documents

Quotes and Ordering

{Identification of 7{alpha
Abdel-Khalik J, et al.
Biochimie, 153, 86-86 (2018)
William J Griffiths et al.
Free radical biology & medicine, 134, 42-52 (2018-12-24)
Using liquid chromatography - mass spectrometry in combination with derivatisation chemistry we profiled the oxysterol and cholestenoic acid content of cerebrospinal fluid from patients with Alzheimer's disease (n = 21), vascular dementia (n = 11), other neurodegenerative diseases (n = 15, Lewy bodies dementia, n = 3, Frontotemporal

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service